Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794742 · ClinicalTrials.gov registry record
Antimicrobial Resistance of Bacteria in Burn Patients
A clinical trial, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT00794742: Completed study, sponsored by Texas Tech University Health Sciences Center.
NCT00794742 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00794742 has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to test the resistance of pathogenic bacteria in infected tissues of burn patients to various antimicrobials and enzyme debriders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-05 |
What the finished NCT00794742 record still lists
NCT00794742 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00794742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00794742 about?
NCT00794742 is a clinical study titled "Antimicrobial Resistance of Bacteria in Burn Patients". The purpose of this study is to test the resistance of pathogenic bacteria in infected tissues of burn patients to various antimicrobials and enzyme debriders.
What is the current status of trial NCT00794742?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-11. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT00794742?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia